Ocuphire Pharma Inc banner

Ocuphire Pharma Inc
NASDAQ:OCUP

Watchlist Manager
Ocuphire Pharma Inc Logo
Ocuphire Pharma Inc
NASDAQ:OCUP
Watchlist
Price: 1.13 USD -3.42% Market Closed
Market Cap: $35.7m

Wall St Price Targets

OCUP Price Targets Summary
Ocuphire Pharma Inc

There are no price targets for OCUP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Ocuphire Pharma Inc Competitors:
Price Targets
VTEX
VTEX
71% Upside
SUDEEPPHRM
Sudeep Pharma Ltd
-40% Downside

Revenue
Forecast

N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Revenue over the next 4 years is 30%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Ocuphire Pharma Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Ocuphire Pharma Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OCUP's stock price target?
Not Available

OCUP does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Ocuphire Pharma Inc?
Projected CAGR
30%

The compound annual growth rate for Revenue over the next 4 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett